{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:25:16Z","timestamp":1787271916971,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Fengxian District Science and Technology Commission Project","award":["20221102"],"award-info":[{"award-number":["20221102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16336-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:15:06Z","timestamp":1781504106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of programmed cell death-related genes in osteosarcoma: inhibiting CIB1 as a promising therapeutic strategy"],"prefix":"10.1186","volume":"26","author":[{"given":"Bin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingding","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"Suppl 2","key":"16336_CR1","doi-asserted-by":"publisher","first-page":"P58","DOI":"10.1359\/jbmr.06s211","volume":"21","author":"MF Hansen","year":"2006","unstructured":"Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget\u2019s disease of bone. J Bone Min Res. 2006;21(Suppl 2):P58\u201363.","journal-title":"J Bone Min Res"},{"key":"16336_CR2","doi-asserted-by":"publisher","first-page":"812395","DOI":"10.3389\/fpubh.2021.812395","volume":"9","author":"J Tang","year":"2021","unstructured":"Tang J, Wang J, Pan XA, Web-Based. Prediction Model for Overall Survival of Elderly Patients With Malignant Bone Tumors: A Population-Based Study. Front Public Health. 2021;9:812395.","journal-title":"Front Public Health"},{"key":"16336_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12943-017-0584-0","volume":"16","author":"AL Leichter","year":"2017","unstructured":"Leichter AL, Sullivan MJ, Eccles MR, Chatterjee A. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. Mol Cancer. 2017;16:15.","journal-title":"Mol Cancer"},{"key":"16336_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ocl.2015.08.022","volume":"47","author":"ME Anderson","year":"2016","unstructured":"Anderson ME. Update on Survival in Osteosarcoma. Orthop Clin North Am. 2016;47:283\u201392.","journal-title":"Orthop Clin North Am"},{"key":"16336_CR5","doi-asserted-by":"publisher","first-page":"e12936","DOI":"10.1111\/cpr.12936","volume":"54","author":"Z Li","year":"2021","unstructured":"Li Z, Li X, Xu D, et al. An update on the roles of circular RNAs in osteosarcoma. Cell Prolif. 2021;54:e12936.","journal-title":"Cell Prolif"},{"key":"16336_CR6","doi-asserted-by":"publisher","first-page":"e210823220109","DOI":"10.2174\/1874467217666230821142839","volume":"17","author":"S Wang","year":"2024","unstructured":"Wang S, Ren Q, Li G, Zhao X, Zhao X, Zhang Z. The Targeted Therapies for Osteosarcoma via Six Major Pathways. Curr Mol Pharmacol. 2024;17:e210823220109.","journal-title":"Curr Mol Pharmacol"},{"issue":"7","key":"16336_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/0109298665314658240712051206","volume":"31","author":"M Wang","year":"2024","unstructured":"Wang M, Li W, Han G, Bai X, Xie J. MicroRNA-605-3p Inhibited the Growth and Chemoresistance of Osteosarcoma Cells via Negatively Modulating RAF1. Protein Pept Lett. 2024;31(7):559\u201368.","journal-title":"Protein Pept Lett"},{"key":"16336_CR8","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022;107:106936.","journal-title":"Int J Surg"},{"key":"16336_CR9","doi-asserted-by":"publisher","first-page":"eabi7127","DOI":"10.1126\/sciadv.abi7127","volume":"8","author":"RS Moubarak","year":"2022","unstructured":"Moubarak RS, de Pablos-Aragoneses A, Ortiz-Barahona V, et al. The histone demethylase PHF8 regulates TGF\u03b2 signaling and promotes melanoma metastasis. Sci Adv. 2022;8:eabi7127.","journal-title":"Sci Adv"},{"key":"16336_CR10","doi-asserted-by":"publisher","first-page":"8636","DOI":"10.1111\/jcmm.15494","volume":"24","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou H, Liu C, et al. HDAC1-mediated deacetylation of LSD1 regulates vascular calcification by promoting autophagy in chronic renal failure. J Cell Mol Med. 2020;24:8636\u201349.","journal-title":"J Cell Mol Med"},{"key":"16336_CR11","doi-asserted-by":"publisher","first-page":"16872","DOI":"10.1038\/s41598-023-43440-z","volume":"13","author":"T Ren","year":"2023","unstructured":"Ren T, Yin N, Du L, Pan M, Ding L. Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis. Sci Rep. 2023;13:16872.","journal-title":"Sci Rep"},{"key":"16336_CR12","doi-asserted-by":"publisher","first-page":"a026104","DOI":"10.1101\/cshperspect.a026104","volume":"6","author":"J Chen","year":"2016","unstructured":"Chen J. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb Perspect Med. 2016;6:a026104.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"16336_CR13","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.7150\/ijbs.96031","volume":"20","author":"MH Xu","year":"2024","unstructured":"Xu MH, Zheng YM, Liang BG, et al. Deubiquitination of CIB1 by USP14 promotes lenvatinib resistance via the PAK1-ERK1\/2 axis in hepatocellular carcinoma. Int J Biol Sci. 2024;20:3269\u201384.","journal-title":"Int J Biol Sci"},{"key":"16336_CR14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1186\/s12885-021-08927-w","volume":"21","author":"S Jacob","year":"2021","unstructured":"Jacob S, B\u00f6sch F, Schoenberg MB, et al. Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis. BMC Cancer. 2021;21:1243.","journal-title":"BMC Cancer"},{"key":"16336_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41418-020-00635-5","volume":"28","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou Y, Zhang P, et al. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma. Cell Death Differ. 2021;28:1026\u201340.","journal-title":"Cell Death Differ"},{"key":"16336_CR16","doi-asserted-by":"publisher","first-page":"200828","DOI":"10.1016\/j.omton.2024.200828","volume":"32","author":"S Fan","year":"2024","unstructured":"Fan S, Fleischer JR, Dokshokova L, et al. High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern. Mol Ther Oncol. 2024;32:200828.","journal-title":"Mol Ther Oncol"},{"key":"16336_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-015-3458-4","volume":"152","author":"JL Black","year":"2015","unstructured":"Black JL, Harrell JC, Leisner TM, et al. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer. Breast Cancer Res Treat. 2015;152:337\u201346.","journal-title":"Breast Cancer Res Treat"},{"key":"16336_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fcell.2020.00280","volume":"8","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Liu J, Zhang C, et al. Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma. Front Cell Dev Biol. 2020;8:280.","journal-title":"Front Cell Dev Biol"},{"key":"16336_CR19","doi-asserted-by":"publisher","first-page":"e1196310","DOI":"10.1080\/2162402X.2016.1196310","volume":"5","author":"Z Wang","year":"2016","unstructured":"Wang Z, Zhang C, Liu X, et al. Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma. Oncoimmunology. 2016;5:e1196310.","journal-title":"Oncoimmunology"},{"key":"16336_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","volume":"21","author":"KC Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. 2015;21:24\u201333.","journal-title":"Trends Mol Med"},{"key":"16336_CR21","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1038\/onc.2017.209","volume":"36","author":"Y Liu","year":"2017","unstructured":"Liu Y, Cheng Y, Xu Y, et al. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers. Oncogene. 2017;36:6143\u201353.","journal-title":"Oncogene"},{"key":"16336_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-016-0539-x","volume":"15","author":"Y Li","year":"2016","unstructured":"Li Y, Liang L, Dai W, et al. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer. Mol Cancer. 2016;15:55.","journal-title":"Mol Cancer"},{"key":"16336_CR23","doi-asserted-by":"publisher","first-page":"e000150","DOI":"10.1136\/esmoopen-2016-000150","volume":"2","author":"A Kitano","year":"2017","unstructured":"Kitano A, Ono M, Yoshida M, et al. Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer. ESMO Open. 2017;2:e000150.","journal-title":"ESMO Open"},{"key":"16336_CR24","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.18632\/oncotarget.6429","volume":"7","author":"S Darb-Esfahani","year":"2016","unstructured":"Darb-Esfahani S, Kunze CA, Kulbe H, et al. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma. Oncotarget. 2016;7:1486\u201399.","journal-title":"Oncotarget"},{"key":"16336_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-023-01895-8","volume":"22","author":"K Nikhil","year":"2023","unstructured":"Nikhil K, Shah K. CDK5: an oncogene or an anti-oncogene: location location location. Mol Cancer. 2023;22:186.","journal-title":"Mol Cancer"},{"key":"16336_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gde.2005.12.001","volume":"16","author":"AA Mills","year":"2006","unstructured":"Mills AA. p63: oncogene or tumor suppressor? Curr Opin Genet Dev. 2006;16:38\u201344.","journal-title":"Curr Opin Genet Dev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16336-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16336-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16336-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:51:08Z","timestamp":1787269868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16336-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16336"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16336-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital (2022-YS-117). All adult participants were fully informed of the study protocol and signed written informed consent. For all minor participants under the age of 16 included in this study, written informed consent was obtained from their parents or legal guardians prior to enrollment. We confirm that all experimental procedures were performed in accordance with relevant national guidelines and regulations, and complied with the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1005"}}